These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 17975143)
1. MCP-1 Promoter Polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment. Tse KP; Tsang NM; Chen KD; Li HP; Liang Y; Hsueh C; Chang KP; Yu JS; Hao SP; Hsieh LL; Chang YS Clin Cancer Res; 2007 Nov; 13(21):6320-6. PubMed ID: 17975143 [TBL] [Abstract][Full Text] [Related]
2. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with psoriasis. Wang L; Yang L; Gao L; Gao TW; Li W; Liu YF Int J Immunogenet; 2008 Feb; 35(1):45-9. PubMed ID: 18093183 [TBL] [Abstract][Full Text] [Related]
3. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival. Liao WT; Song LB; Zhang HZ; Zhang X; Zhang L; Liu WL; Feng Y; Guo BH; Mai HQ; Cao SM; Li MZ; Qin HD; Zeng YX; Zeng MS Clin Cancer Res; 2007 Jan; 13(2 Pt 1):508-14. PubMed ID: 17255272 [TBL] [Abstract][Full Text] [Related]
4. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma]. Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265 [TBL] [Abstract][Full Text] [Related]
5. [Correlation of pretreatment serum level of endostatin to posttreatment distant metastasis in patients with advanced nasopharyngeal carcinoma]. Zhao ZJ; Mo HY; Zhang CQ; Qi B; Li J; Hong MH; Mai HQ Ai Zheng; 2007 Nov; 26(11):1243-7. PubMed ID: 17991326 [TBL] [Abstract][Full Text] [Related]
6. Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma. Ben Nasr H; Chahed K; Mestiri S; Bouaouina N; Snoussi K; Chouchane L Hum Immunol; 2007 Sep; 68(9):761-9. PubMed ID: 17869651 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas. Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818 [TBL] [Abstract][Full Text] [Related]
8. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma. Lee CC; Chu ST; Chou P; Lee CC; Chen LF Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377 [TBL] [Abstract][Full Text] [Related]
9. [Relationship between VEGF-C expression and nasopharyngeal carcinoma proliferation and metastasis]. Shi XY; Hu GQ; Yuan XL; Li HY; Liu YQ; Ma D Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):364-7. PubMed ID: 17045002 [TBL] [Abstract][Full Text] [Related]
10. Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma. Wu D; Ding Y; Wang S; Zhang Q; Liu L J Pathol; 2008 Oct; 216(2):167-75. PubMed ID: 18680137 [TBL] [Abstract][Full Text] [Related]
11. The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients. Bachmann HS; Otterbach F; Callies R; Nückel H; Bau M; Schmid KW; Siffert W; Kimmig R Clin Cancer Res; 2007 Oct; 13(19):5790-7. PubMed ID: 17908970 [TBL] [Abstract][Full Text] [Related]
12. The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma. Chang KP; Hao SP; Lin SY; Ueng SH; Pai PC; Tseng CK; Hsueh C; Hsieh MS; Yu JS; Tsang NM Laryngoscope; 2006 Apr; 116(4):541-6. PubMed ID: 16585856 [TBL] [Abstract][Full Text] [Related]
13. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories. Ma J; Liu L; Tang L; Zong J; Lin A; Lu T; Cui N; Cui C; Li L Clin Cancer Res; 2007 Mar; 13(5):1445-52. PubMed ID: 17332287 [TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma. Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741 [TBL] [Abstract][Full Text] [Related]
15. Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes. Chang KP; Hao SP; Chang JH; Wu CC; Tsang NM; Lee YS; Hsu CL; Ueng SH; Liu SC; Liu YL; Wei PC; Liang Y; Chang YS; Yu JS Clin Cancer Res; 2008 Nov; 14(21):6979-87. PubMed ID: 18980993 [TBL] [Abstract][Full Text] [Related]
16. Association of IL-1B gene polymorphisms with nasopharyngeal carcinoma in a Chinese population. Zhu Y; Xu Y; Wei Y; Liang W; Liao M; Zhang L Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):207-11. PubMed ID: 18289837 [TBL] [Abstract][Full Text] [Related]
17. A single nucleotide polymorphism in the E-cadherin gene promoter -160 C/A is associated with risk of nasopharyngeal cancer. Ben Nasr H; Hamrita B; Batbout M; Gabbouj S; Bouaouina N; Chouchane L; Chahed K Clin Chim Acta; 2010 Sep; 411(17-18):1253-7. PubMed ID: 20462505 [TBL] [Abstract][Full Text] [Related]
18. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482 [TBL] [Abstract][Full Text] [Related]
19. Functional vascular endothelial growth factor -2578 C/A polymorphism in relation to nasopharyngeal carcinoma risk and tumor progression. Nasr HB; Chahed K; Bouaouina N; Chouchane L Clin Chim Acta; 2008 Sep; 395(1-2):124-9. PubMed ID: 18588866 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of bcl-2 expression on advanced nasopharyngeal carcinoma. Chen MK; Lai JC; Chang CC; Chang JH; Chang YJ; Chen HC Head Neck; 2008 Aug; 30(8):1052-7. PubMed ID: 18442057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]